Updated on 10 June 2013
A citizen lawsuit tried to force action against Ranbaxy in India
New Delhi: An Indian lawyer has filed a lawsuit asking the country's Supreme Court to probe the pharmaceutical giant, its executives and even the Indian regulators.
The country's generic giant, Ranbaxy Laboratories had in May this year made a $500 million settlement to the US FDA after accepting to have sold adulterated drugs in the US market.
The public interest litigation (PIL) urged the Supreme Court to shut down the two manufacturing plants identified by the US FDA and further wants the court to order the country's Central Bureau of Investigation (CBI) to investigate the US case. The suit further claimed that corruption within the organisation prevailed because of lax Indian regulation and hence it seeks a probe of regulators who oversaw the company.